Avance® Nerve Graft Receives Product Innovation Leadership Award

“AxoGen has been awarded the 2014 Product Innovation Leadership Award for Peripheral Nerve Repair from research organization Frost & Sullivan in recognition for the development and commercialization of Avance® Nerve Graft.  Following extensive independent research by Frost & Sullivan’s Best Practices team, Avance® Nerve Graft was honored for the unique features and benefits it offers to the peripheral nerve repair market.”

AxoGen is an Industry Partner for the J. Crayton Pruitt Family Department of Biomedical Engineering. In addition, Karen Zaderej, who is the CEO of AxoGen, is a member of the External Advisory Board for UF BME.

Read more at MarketWatch.com.

 

Leave a Reply